On average, what percentage of your patients has an LDL-C level of >200 mg/dL?  
0%–10%
10%–30%
30%–50%
>50%  

Typically, what is your initial treatment strategy for these patients? 
Lifestyle changes alone
Moderate lipid-lowering therapy in conjunction with lifestyle changes
Aggressive lipid-lowering combination therapy (eg, statin + ezetimibe) in conjunction with lifestyle changes
Aggressive lipid-lowering therapy with a single agent (eg, statin) in conjunction with lifestyle changes
Assuming some of these patients have persistent LDL-C elevations despite aggressive lipid-lowering treatment with either a single agent (eg, statin) or combination therapy (eg, statin + ezetimibe) and lifestyle interventions for 6 months, what would your next recommendation be? 
Continue aggressive lipid-lowering therapy indefinitely
Refer to a specialist
Continue aggressive lipid-lowering therapy and refer for LDL-apheresis
Discontinue aggressive lipid-lowering therapy and refer for LDL-apheresis
Choose the statement below that best reflects your knowledge regarding LDL-apheresis therapy.  I am familiar with this therapy and have referred patients for it
I am familiar with this therapy but have not referred patients for it
I am somewhat familiar with this therapy and am interested in learning more about it
I have limited or no knowledge about this therapy but am interested in learning more about it
In the past 5 years, how many patients have you referred for LDL-apheresis therapy? 
0
1–5
5–10
>10

If you do not currently refer or have not referred qualified patients for LDL-apheresis therapy, please indicate your reasoning below.


Are you a specialist or PCP? 
Specialist
PCP
Other: Please specify


Please explain in your own words the LDL-apheresis treatment procedure.